Open Access‘Tamsulosin and Darifenacin’ Versus ‘Tamsulosin Monotherapy’ for ‘BPH with Accompanying Overactive Bladder’
Author(s) -
Iqbal Singh
Publication year - 2015
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2015/12526.6019
Subject(s) - tamsulosin , overactive bladder , medicine , urology , international prostate symptom score , tolterodine , placebo , urinary incontinence , urination , solifenacin , lower urinary tract symptoms , prostate , urinary system , hyperplasia , alternative medicine , pathology , cancer
To evaluate the efficacy/safety of 'tamsulosin and darifenacin' (TD) vs. 'tamsulosin and placebo' (TP) for patients with symptomatic benign prostrate hyperplasia (BPH) with accompanying overactive bladder (OAB) symptoms.